Crossmark

Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy

Crossref DOI link: https://doi.org/10.1186/s13075-018-1719-4

Published Online: 2018-10-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Di Benedetto, Paola http://orcid.org/0000-0003-2927-8703
Liakouli, Vasiliki

Ruscitti, Piero

Berardicurti, Onorina

Carubbi, Francesco

Panzera, Noemi

Di Bartolomeo, Salvatore

Guggino, Giuliana

Ciccia, Francesco

Triolo, Giovanni

Cipriani, Paola

Giacomelli, Roberto
License Information

Text and Data Mining valid from 2018-10-03
More Information

Article History

Received: 6 June 2018

Accepted: 10 September 2018

First Online: 3 October 2018

Ethics approval and consent to participate

: The experiments reported in this article comply with the current ethical standard laws of Italy. All patients gave fully informed written consent approved by the institutional ethics committee.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below